MENU

Epigenetics Symposium: From Genes to Chromatin to Therapeutics

Date & Time

Wednesday, March 2, 2022
8:30am to 7:00pm

Location

The Franklin Institute
222 N 20th St
Philadelphia, PA 19103

Registration Information

This event is complimentary but pre-registration is required. A virtual option is available for this event, please indicate if you are signing up for in-person or virtual when you register.

Register for Event

Schedule

Program: 8:30 AM - 5:30 PM
Reception: 5:30 PM - 7:00 PM

8:00 AM Registration & Light Breakfast
8:50 – 9:00 AM Welcome by Johnathan Whetstine, PhD
9:00 – 9:25 AM Daniel De Carvalho, PhD – University of Toronto
9:25 – 9:50 AM Chuan He, PhD – University of Chicago
9:50 – 10:15 AM Karen Adelman, PhD – Harvard Medical School
10:15 – 10:20 AM Keynote Introduction
10:20 – 11:05 AM Robert Roeder, PhD - The Rockerfeller University
11:05 – 11:25 AM Break
11:25 – 11:50 AM Gerd Blobel, MD, PhD – Children’s Hospital of Philadelphia
11:50 AM – 12:15 PM Nada Jabado, MD, PhD – McGill University
12:15 – 2:00 PM Lunch/Poster Session
2:00 – 2:25 PM Jian Jin, PhD – Icahn School of Medicine at Mount Sinai
2:25 – 2:50 PM Yael David, PhD – Memorial Sloan Kettering Cancer Center
2:50 – 4:10 PM Industry Panel – Epigenetic Therapeutic Opportunities
4:10 – 4:30 PM Break
4:30 – 4:55 PM Scott Armstrong, MD, PhD – Dana-Farber Cancer Institute, Harvard
4:55 – 5:20 PM Anjana Rao, PhD – La Jolla Institute for Immunology
5:20 – 5:30 PM Closing Remarks

 

Speakers

Keynote Speaker: Dr. Robert G. Roeder, The Rockefeller University

  • Dr. Daniel De Carvalho, University of Toronto
  • Dr. Chuan He, University of Chicago
  • Dr. Karen Adelman, Harvard Medical School
  • Dr. Gerd Blobel, Children’s Hospital of Philadelphia
  • Dr. Nada Jabado, McGill University
  • Dr. Jian Jin, Icahn School of Medicine at Mount Sinai
  • Dr. Yael David, Memorial Sloan Kettering Cancer Center
  • Dr. Scott Armstrong, Dana-Farber Cancer Institute, Harvard
  • Dr. Anjana Rao, La Jolla Institute for Immunology

The event will also feature an afternoon speaker session with leading industry members discussing epigenetic-related therapies. Panelists include:

  • AstraZeneca
  • Daiichi Sankyo
  • Epizyme
  • Foghorn Therapeutics“Targeting Transcription Factor-BAF interactions in Cancer” - Asad Taherbhoy, PhD
  • Incyte - "Targeting BET Bromodomain Proteins for the Treatment of Cancer" - Susan Wee, PhD
  • Oryzon Genomics - “Iadademstat, paving the way to new therapies in AML and SCLC” - Ana Limón, PhD
  • Vyne Therapeutics

Thank You to Our Sponsors!

Agios

Arima Genomics

Astra Zeneca

Azenta

Cell Press

Cell Signaling Technology

Daiichi-Sankyo

EpiCypher

Epizyme

Foghorn

Illumina

Incyte

Mission Bio

Novogene

Oryzon Genomics

Qsonica

Thermo Fisher

Twist Bioscience

Vyne

Connect with Fox Chase